Esperion Therapeutics, Inc. Announces Pricing of Initial Public Offering
June 26, 2013Esperion priced its IPO of 5M shares of common stock at $14/share. Esperion is a clinical-stage company developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies to treat hypercholesterolemia.
More »
Domain Associates Announces Promotion of Nimesh Shah to Partner
June 12, 2013Nimesh has done significant work in the medical device space. He is a co-founder of Zyga Technology and is a board member of Benvenue Medical, Cotera, Miramar Labs, Sequent Medical, Zyga, and The Foundry, a medical devices incubator.
More »
Clovis Oncology Announces Upsizing and Pricing of Public Offering of Common Stock
June 11, 2013Clovis (NASDAQ:CLVS) announced the pricing of an underwritten public offering of 3,333,334 shares of its common stock at $72.00 per share, before underwriting discounts and commissions. The size of the offering was upsized from $170M to $240M.
More »